Tuesday, April 28, 2026

#biotech

7 articles

NVIDIA Targets Pharma Revenue with BioNeMo Platform as AI Biotech Infrastructure Spending Accelerates

Sector Analysis

NVIDIA Targets Pharma Revenue with BioNeMo Platform as AI Biotech Infrastructure Spending Accelerates

Salvado•Apr 11, 2026

Vectus Biosystems faces delisting risk as asset sale proceeds may fall short of operational needs

Vectus Biosystems faces delisting risk as asset sale proceeds may fall short of operational needs

ViaNews Editorial Team (Markets)•Feb 23, 2026

Jade Biosciences JADE301 Phase 1 Trial Set for March 2027 Start in Autoimmune Space

Healthcare Equities

Jade Biosciences JADE301 Phase 1 Trial Set for March 2027 Start in Autoimmune Space

ViaNews Editorial Team (Markets)•Feb 21, 2026

Biotech's Commercial Inflection Point: Regeneron, Moderna, CRISPR Therapeutics, and REGENXBIO Approach Revenue-Generating Threshold

Healthcare Sector Trading

Biotech's Commercial Inflection Point: Regeneron, Moderna, CRISPR Therapeutics, and REGENXBIO Approach Revenue-Generating Threshold

ViaNews Editorial Team (Markets)•Feb 18, 2026

Four Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research Cycle

Four Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research Cycle

ViaNews Editorial Team (Markets)•Feb 15, 2026

Illumina Q4 Earnings: Can Genomics Leader Sustain Growth?

Illumina Q4 Earnings: Can Genomics Leader Sustain Growth?

ViaNews Editorial Team (Markets)•Feb 4, 2026

Guardant Health Reports Strong Q4 Revenue Growth Amid Market Competition

Guardant Health Reports Strong Q4 Revenue Growth Amid Market Competition

ViaNews Editorial Team (Markets)•Jan 12, 2026